DHR vs INVA: fair value comparison
Danaher Corporation and Innoviva, Inc. · Updated 2026-09-06
Both currently screen as fairly valued on TickrTrends' Forward Fair Value model. Within Healthcare, INVA currently sits closer to the top of our discount ranking.
| DHR | INVA | |
|---|---|---|
| Verdict | Fairly valued | Fairly valued |
| Last price | $207.66 | $20.77 |
| 12-month range | $175.15–$230.40 | $18.11–$23.41 |
| Sector rank | #62 of 113 Healthcare | #60 of 113 Healthcare |
| Quality grade | B | B |
| Leverage | Low | Low |
| Margin trend | Expanding | — |
| Revenue growth | Declining | — |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | — | Downtrend |
| DCF cross-check | Overvalued | — |
| 52-week position | The upper-middle quarter | The upper-middle quarter |
Full single-stock breakdowns: DHR fair value analysis · INVA fair value analysis